Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • When typing in this field, a list of search results will appear and be automatically updated as you type.

  • Request More Information
  • Journalists
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • General Inquiries
  • Worldwide Offices
  • Request More Information
  • Journalists

Fullife Triggers a Radical Shift Towards Lifestyle OTC Drugs Using the Latest Effervescent Delivery Science


News provided by

Fullife Healthcare Private Limited

10 Oct, 2017, 18:42 IST

Share this article

Share toX

Share this article

Share toX

Fullife Healthcare Private Limited Logo (PRNewsfoto/Fullife Healthcare Private Ltd.)
Fullife Healthcare Private Limited Logo (PRNewsfoto/Fullife Healthcare Private Ltd.)

MUMBAI, October 10, 2017 /PRNewswire/ --

Company expands its portfolio of cutting-edge OTC drugs for preventive care and active living, through its differentiated and innovative Effervescent Drug Delivery platform 

Mumbai-based Fullife Healthcare Private Limited is ushering in a paradigm shift in India's lifestyle drug market, using innovative effervescent products. The company, which commenced its Indian operations in 2010, specialises in innovative OTC drugs with a primary focus on preventive medication using novel drug delivery formats. Fullife is capitalising on proprietary technologies that it acquired from Switzerland-based Novelty Pharma, to manufacture a range of differentiated effervescent products.

     (Logo: http://mma.prnewswire.com/media/570614/Fullife_Healthcare_Logo.jpg )

Through its rich portfolio, Fullife aims to ride on projected growth of the global effervescent market. According to the company, the global effervescent market is projected to move upwards of US$50 billion by 2025. In particular, the company's products are designed to appeal to the well-informed and health-conscious consumers that believe in preventive care and active living.

'Prevention' is the new Mantra 

With consumer demand for wellness services and preventive medication growing at a healthy tick, the opportunity for innovation-driven preventive healthcare OTC products is vast. The global wellness industry is estimated to be in the region of US$3 trillion, according to the company, that makes it three times larger than the US$1 trillion worldwide pharmaceutical industry. Of this, preventive medicine is valued at approximately US$500 billion. Key factors driving the market expansion for preventive medicine include the growing awareness about preventive measures which enhance the quality of life, lifespan and minimise the possible healthcare spend.

Preventive medicine is currently growing the fastest in markets that can afford access to cutting-edge technologies, and have the potential to become truly global in time. In these affluent markets, there is a fundamental shift taking place in the collective attitude towards health and how to manage it. This way of thinking is rapidly permeating into other fast-growing emerging markets, such as India, as large segments of well-informed GEN-Y and GEN-X people are opting to adopt similar 'active-living' lifestyles to stay healthy and prevent illness.

With the world's youngest population and fastest-growing middle-class in the world, India as a market is ripe for the picking. Historically, India has always been a market where drugs were primarily made to meet low-income affordability norms. Now, over the last decade, India has witnessed the emergence of a fast-growing middle-class that can afford and demand a larger variety of modern, value-added OTC options. This segment had remained underserved until now. Fullife is addressing this demand-supply gap by using mature and established Swiss effervescent technologies and creating unique and differentiated OTC products aimed specifically towards Indian tastes and sensibilities.

The Effervescent 'Edge' 

The oral delivery system provides several compliance and functional benefits. Nutraceuticals enjoy the ability to be packed into large doses of active ingredients, figuring in the realm of daily dietary supplements and specialised drugs. Since effervescent products are dissolved before they are ingested, they allow active ingredients to be solubilised or dispersed before reaching the system, thus speeding up absorption and bioavailability. In Europe, many vitamins, minerals and even key drugs, are being delivered via effervescent means since a long time, capturing a significant market share. Another striking edge is its multi-sensory in-use experience. It is an extremely convenient, portable and an easy-to-use dosage form, delivering a positive, refreshing and beneficial experience.

According to Mr. Varun Khanna, Director - Business Development, Fullife Healthcare, "Due to their innate nature, effervescent products have one of the fastest bio-absorptions as a dosage format. Fullife has strategically embraced this delivery science, and translated it into a wide range of branded products, the leading one being 'Fast&Up'."

A 'Smart' Business Model 

The company has been gathering pace over the last 4 years by setting up appropriate manufacturing capabilities; getting all regulatory product approvals; setting up its sales and distribution network; and the appropriate logistical support to facilitate sales. "India is at the crux of an intensifying trend towards lifestyle OTC products, with a growing number of healthcare spenders preferring preventive medicine over 'disease-driven products'. We are proud to make a large variety of world-class products accessible to Indian consumers," added Mr. Khanna.

The company's business model benefits from a unique combination of using the ideal drug delivery technologies; manufacturing in India with an Asian cost base; and having a wide global presence to address the global marketplace. Fullife intends to create a rich portfolio of products that address certain acute and chronic therapeutic areas. "Our marketing strategy is aimed at building a world-wide model through distributors and alliance partners to create a solid branded business. In time, we hope to become a transnational company, with a dynamic portfolio of brands that have global appeal," concurred Mr. Satish Khanna, Chairman, Fullife Healthcare.

About Fullife Healthcare Private Limited: 

Mumbai-based Fullife Healthcare Private Limited is committed to revolutionise health management through trending innovation, global alliances and an asset-light, smart-manufacturing business model. The company brings a fresh perspective to healthcare management, in which 'Prevention is The New Cure'. Fullife's growing portfolio of clinically approved, branded, pharmaceutical, nutraceutical and cosmeceutical OTC products - are available in 22 countries across the globe, including India. Fullife's flagship brand 'Fast&Up' has gained wide acceptance by the rapidly growing 'up-market' consumer segment, that comprises discerning users who believe in an 'Active Living' lifestyle.

For more information, please contact:
Fullife Healthcare Private Limited
Varun Khanna
+91-98200-10632
[email protected]

Dickenson Financial PR
Mehul Mehta
+91-98202-80325
[email protected]

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.